Please use this identifier to cite or link to this item:
https://etd.cput.ac.za/handle/20.500.11838/1457
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Van Rijswijk, A.W | en_US |
dc.contributor.advisor | Robson, R. | en_US |
dc.contributor.author | Jooste, Marius Johannes | en_US |
dc.date.accessioned | 2012-09-26T13:15:53Z | - |
dc.date.accessioned | 2016-02-22T04:57:48Z | - |
dc.date.available | 2012-09-26T13:15:53Z | - |
dc.date.available | 2016-02-22T04:57:48Z | - |
dc.date.issued | 1988 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11838/1457 | - |
dc.description | Thesis (Masters Diploma (Technology))--Cape Technikon, Cape Town,1988. | en_US |
dc.description.abstract | Nosocomical or hospital-aqired infection, can be defined as an infection not present when the patient enters a hospital. It usually manifests itself seventy two hours after admission and sometimes it is not apparent until after the patient has been discharged. When the incubation period is unknown, any infection developing after admission to a hospital, may be classified as a nosocomical infection. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Cape Technikon | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/za/ | - |
dc.subject | Infection | en_US |
dc.subject | Medical microbiology | en_US |
dc.title | The in vitro antimicrobial activity of amikacin and ceftazidime against multiple resistant gram-negative bacilli in nosocomial infections | en_US |
dc.type | Thesis | en_US |
Appears in Collections: | Biomedical Technology - Masters Degrees |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The in-vitro antimicrobial activity of amikacin & ceftazidine.pdf | 2.35 MB | Adobe PDF | ![]() View/Open |
Page view(s)
2,543
Last Week
0
0
Last month
1
1
checked on Apr 10, 2025
Download(s)
276
checked on Apr 10, 2025
Google ScholarTM
Check
This item is licensed under a Creative Commons License